All News

The tool will let pump users get updates of new features in between replacement of their hardware.

According to the study published in Cancer, adjuvant chemotherapy in patients with early stage colon cancer results in clinically relevant improvement in overall survival.

Also, the share of employers funding wellness programs has passed the 50% mark, but not all employees use them.

The most recent Kaiser Health Tracking Poll was conducted during an exceptionally violent week. Concerns about terrorism and gun policy outranked jobs and the economy and healthcare as voter priorities.

The Pew Charitable Trusts has proposed several ideas to address substance use disorders by focusing on developing and supporting policies such as the proposed rule to increase the patient limit for qualifying physicians to treat opioid use disorders.

The authors say patients with cancer and dementia were more likely to have palliative care consultations and DNR orders.

Faulty assumptions about the best ways to address the needs of minority patients may be lead to racial and ethnic disparities in the treatment of mental health and substance use disorders.

The top stories in managed care this week included coverage of JAMA’s special issue on healthcare transformation under the ACA, changes in the proposed 2017 Physician Fee Schedule promoting value-based care, and more.

Highlights of coverage of our peer-reviewed research in the healthcare and mainstream press.

A new study in Health Affairs suggests antipsychotic use among Medicaid children peaked in 2008 and has slowed since that time, but this remains a policy challenge.

Despite their known risk, only half the women over 85 years of age in a cohort being evaluated had their baseline bone density tested prior to initiating treatment.

Physician groups like some part of the new fee plan but find other overly burdensome.

What We’re Reading, July 15, 2016: What can the 7 remaining co-ops do to survive; CMS projects increased Medicare spending per enrollee by 2025; and experts call for policy changes to support the health of prisoners at high risk for HIV.

Making medical decisions is not as easy as following the evidence. When dealing with people, there are a number of anomalies that influence the decisions someone might make.

Loss-of-function mutations in Janus kinase 1 (JAK1) or Janus kinase 2 (JAK2), deletion of the wild-type allele of JAK1 or JAK2, and truncation in the antigen-presenting protein beta-2-microglobulin gene were found responsible for lack of response to interferon gamma.

Researchers found health benefits even for those who started cycling close to retirement.

Acting CMS Administrator Andy Slavitt told the Senate Finance Committee there are concerns that some primary care practices will not be ready for the targeted January 1, 2017, start date.

What We’re Reading, July 14, 2016: Inaccurate provider directories in California health plans; atehnahealth survey identifies low physician engagement; and opioid addiction bill will soon be law.

A study has found that an 8-gene signature score, combined with nodal status and tumor size, obtained from the EndoPredict breast cancer test might be more accurate at predicting the recurrence of breast cancer, compared with the recurrence score of Oncotype DX.

The analysis pinpointed which countries faced an elevated risk of spreading Zika just based on anticipated travel by athletes and delegates to the Games in Rio de Janiero.

The study of 3.9 million adults culled data from 189 studies; participants were non-smokers who had no known chronic disease and lived at least 5 years to be included in the analysis.

The ROCKET trial was halted last week following news of 3 patient deaths due to cerebral edema.

Of the original 7 hospital groups, only 3 are still challenging New Jersey's largest insurer over its creation of a tiered network plan.

What We’re Reading, July 13, 2016: Humira faces competition from a biosimilar; Washington, DC, campaigns to raise awareness on anti-HIV PrEP pills; and veterans may have been incorrectly diagnosed for traumatic brain injury...or not.

Researchers assessed balugrastim’s efficacy, safety, and tolerability in 4 different clinical trials and found it to be a suitable alternative to pegfilgrastim in regard to reducing the mean duration of severe neutropenia.

Promotional advertising by cancer centers has seen a dramatic spike in recent years, with 890 cancer centers spending $173 million for advertising in 2014.

What We're Reading, July 12, 2016: Oregon's Health CO-OP to close down by the end of July; experts discuss fairer ways to decide on drug pricing; and gender bias in physician salaries at academic institutions.

Researchers examined genetic information from 120,000 people from across the globe. The effort involved more than 300 scientists, including NIH's Francis Collins, MD, PhD.

The National Cancer Institute (NCI) estimates that the aging US population will contribute to a substantial increase in the number of older cancer survivors over the next 25 years.

The president predicts that in 20 years, the nation will look back on "Obamacare" as a moment of courage that has improved people's lives.